CNTX
NASDAQ
$0.62
Context Therapeutics Inc (CNTX)
Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of chronic pain. The company is headquartered in Boston, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $5.38 (+773.38%)
Market Cap
$58M
Free Cash Flow Yield
-56.68%
Beta (5Y)
0.76
Price Chart
Valuation
Market Cap$58M
P/B1.08
Profitability
EBITDA-$44M
EPS-$0.35
Financial Health
Free Cash Flow Yield-56.68%
Growth & Risk
Beta (5Y)0.76
Sharpe Ratio0.16